NDMM: Background and treatment strategies
Module 1 introduces newly diagnosed multiple myeloma (NDMM) and the assessment of transplant eligibility. It reviews the epidemiology of the disease, the patient- and disease-related factors that determine eligibility for autologous stem cell transplantation, the challenges in making that assessment, and the NDMM treatment pathway. After this module you will be able to identify the key factors determining transplant eligibility, and compare treatment approaches for transplant-eligible and transplant-ineligible patients with NDMM.
Accreditation
Accreditation for this e-learning has been granted for X points by:
TBD
Obtain CME points
To obtain CME points, you must answer at least 70% of the questions in the final test correctly. If you have a lower score, you can retake the final test twice more. You can pause the e-learning and then resume where you paused.
